Viewing Study NCT06064656


Ignite Creation Date: 2025-12-24 @ 11:17 PM
Ignite Modification Date: 2026-04-10 @ 2:48 AM
Study NCT ID: NCT06064656
Status: COMPLETED
Last Update Posted: 2025-07-03
First Post: 2023-09-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Non-Interventional Study of Clinical Characteristics and Mortality of US Patients With Fibrodysplasia Ossificans Progressiva (FOP)
Sponsor: Regeneron Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Fibrodysplasia Ossificans Progressiva (FOP) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Genetic disease View
None Heterotopic ossification (HO) View
None Skeletal dysplasia View
None Activin A receptor, type I (ACVR1) View